Medicare site neutral payment policy (No specific legislation) Prevent cuts to the Medicare Physician Fee Schedule, (S. 1640, H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1 Impose restrictions on prior authorization practices used by Medicare Advantage plans (S. 1816, H.R. 3514) Ask Congress to amend Section 1847A(c)(4) of the Social Security Act to extend the Secretary of Health and Human Services authority to use the wholesale acquisition cost (WAC) plus 3% as the reimbursement methodology for drugs under Medicare Part B until the Average Sales Price (ASP) reaches sustainable levels, as determined by the Secretary. This change will allow biosimilars administered in office settings to be reimbursed adequately so that physicians can afford to prescribe and administer biosimilars. (No specific legislation)
Literal federal measure citations: S. 1640, H.R. 879, H.R. 1, S. 1816, H.R. 3514